Zydus Life. The Central Drugs Standard Control Organisation (CDSCO) has granted restricted emergency use authorisation to the ZyCoV-D vaccine last year.
The DNA vaccine produced by Ahmedabad-based Zydus Cadila is a three-dose vaccine. ZyCoV-D is to be administered 28 days apart.
The vaccine was given emergency use authorisation (EUA) by the drug regulator on August 20. It is the first DNA plasmid vaccine in the world for human use, developed indigenously by the company against the Covid-19 virus.
It is also the first Covid vaccine that is needle-free and administered using PharmaJet, a needle-free applicator to ensure painless intradermal vaccine delivery which also leads to a significant reduction in any kind of major side effects.